The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Functional diffusion map: A noninvasive MRI biomarker for early stratification of clinical brain tumor response
Open accessAbstract
Assessment of radiation and chemotherapy efficacy for brain cancer patients is traditionally accomplished by measuring changes in tumor size several months after therapy has been administered. The ability to use noninvasive imaging during the early stages of fractionated therapy to determine whether a particular treatment will be effective would provide an opportunity to optimize individual patient management and avoid unnecessary systemic toxicity, expense, and treatment delays. We investigated whether changes in the Brownian motion of water within tumor tissue as quantified by using diffusion MRI could be used as a biomarker for early prediction of treatment response in brain cancer patients. Twenty brain tumor patients were examined by standard and diffusion MRI before initiation of treatment. Additional images were acquired 3 weeks after initiation of chemo- and/or radiotherapy. Images were coregistered to pretreatment scans, and changes in tumor water diffusion values were calculated and displayed as a functional diffusion map (fDM) for correlation with clinical response. Of the 20 patients imaged during the course of therapy, 6 were classified as having a partial response, 6 as stable disease, and 8 as progressive disease. The fDMs were found to predict patient response at 3 weeks from the start of treatment, revealing that early changes in tumor diffusion values could be used as a prognostic indicator of subsequent volumetric tumor response. Overall, fDM analysis provided an early biomarker for predicting treatment response in brain tumor patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Response criteria for phase II studies of supratentorial malignant glioma.
Macdonald, D. R., Cascino, T. L., Schold, S. C., & Cairncross, J. G. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.7.1277 · Cited by 2,409
Cited by
Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas
Dhermain, F. G., Hau, P., Lanfermann, H., Jacobs, A. H., & van den Bent, M. J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70181-2 · Cited by 368
Diffusion-Tensor MR Imaging and Tractography: Exploring Brain Microstructure and Connectivity
Nucifora, P. G. P., Verma, R., Lee, S.-K., & Melhem, E. R. (2007) · Radiology · doi:10.1148/radiol.2452060445 · Cited by 344
Koh, D.-M., Scurr, E., Collins, D., Kanber, B., Norman, A., Leach, M. O., & Husband, J. E. (2007) · American Journal of Roentgenology · doi:10.2214/ajr.06.0601 · Cited by 344
Advances in neuro-oncology imaging
Langen, K.-J., Galldiks, N., Hattingen, E., & Shah, N. J. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.44 · Cited by 339
Hamstra, D. A., Chenevert, T. L., Moffat, B. A., Johnson, T. D., Meyer, C. R., Mukherji, S. K., Quint, D. J., Gebarski, S. S., Fan, X., Tsien, C. I., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508347102 · Cited by 287
Self-citation
Metadata
- Authors
- Moffat, B. A., Chenevert, T. L., Lawrence, T. S., Meyer, C. R., Johnson, T. D., Dong, Q., Tsien, C., Mukherji, S., Quint, D. J., Gebarski, S. S., Robertson, P. L., Junck, L. R., Rehemtulla, A., & Ross, B. D.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2005-04
- Volume
- 102
- Issue
- 15
- Pages
- 5524-5529
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2070540496
- Cited by
- 643
- References
- 1
- FWCI
- 24.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Functional diffusion map: A noninvasive MRI biomarker for early stratification of clinical brain tumor response. https://app.cochat.ai/papers/10.1073/pnas.0501532102
- The paper
- Moffat, B. A., Chenevert, T. L., Lawrence, T. S., Meyer, C. R., Johnson, T. D., Dong, Q., Tsien, C., Mukherji, S., Quint, D. J., Gebarski, S. S., Robertson, P. L., Junck, L. R., Rehemtulla, A., & Ross, B. D. (2005). Functional diffusion map: A noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0501532102
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.